|
|
|
Insider
Information: |
Moran Sean F. |
Relationship: |
|
City: |
Columbia |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
143,605 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$953,516 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
143,605 |
|
|
Total
Value |
$953,516 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
3,232.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Celsion Corp |
CLSN |
Chief Financial Officer |
2009-03-17 |
35,000 |
2009-01-19 |
0 |
Premium* |
|
Invivo Therapeutics Holdings Cor... |
NVIV |
Acting Chief Financial... |
2013-09-03 |
60,000 |
2013-08-29 |
0 |
Premium* |
|
Corbus Pharmaceuticals Holdings,... |
CRBP |
|
2024-06-18 |
48,605 |
2014-11-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
67 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2020-12-21 |
4 |
OE |
$1.40 |
$122,500 |
D/D |
87,500 |
437,110 |
0 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2022-03-10 |
4 |
B |
$0.37 |
$5,550 |
D/D |
15,000 |
167,272 |
2.74 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2022-05-16 |
4 |
B |
$0.30 |
$3,600 |
D/D |
12,000 |
179,272 |
2.66 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2022-08-10 |
4 |
B |
$0.26 |
$5,198 |
D/D |
20,000 |
199,272 |
2.74 |
% |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2024-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
40,176 |
46,818 |
0 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2024-04-10 |
4 |
OE |
$30.00 |
$53,610 |
D/D |
1,787 |
48,605 |
0 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2024-06-14 |
4 |
AS |
$49.87 |
$466,569 |
D/D |
(9,355) |
48,605 |
0 |
% |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2024-06-14 |
4 |
OE |
$4.26 |
$80,187 |
D/D |
9,355 |
56,393 |
0 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2024-06-17 |
4 |
AS |
$46.77 |
$314,789 |
D/D |
(6,730) |
48,605 |
0 |
% |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2024-06-17 |
4 |
OE |
$14.10 |
$94,893 |
D/D |
6,730 |
55,335 |
0 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2024-06-18 |
4 |
AS |
$42.12 |
$82,479 |
D/D |
(1,958) |
48,605 |
0 |
% |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2024-06-18 |
4 |
OE |
$30.00 |
$58,740 |
D/D |
1,958 |
50,563 |
0 |
- |
|
NVIV |
Invivo Therapeutics Holdi... |
Acting Chief Financial Officer |
|
2013-08-29 |
4 |
S |
$1.23 |
$34,440 |
D/D |
(28,000) |
28,000 |
0 |
- |
|
NVIV |
Invivo Therapeutics Holdi... |
Acting Chief Financial Officer |
|
2013-08-29 |
4/A |
B |
$1.23 |
$34,440 |
D/D |
28,000 |
28,000 |
2.74 |
- |
|
NVIV |
Invivo Therapeutics Holdi... |
Acting Chief Financial Officer |
|
2013-08-30 |
4 |
S |
$1.47 |
$17,640 |
D/D |
(12,000) |
40,000 |
0 |
- |
|
NVIV |
Invivo Therapeutics Holdi... |
Acting Chief Financial Officer |
|
2013-08-30 |
4/A |
B |
$1.47 |
$17,640 |
D/D |
12,000 |
40,000 |
2.74 |
- |
|
NVIV |
Invivo Therapeutics Holdi... |
Acting Chief Financial Officer |
|
2013-09-03 |
4 |
B |
$1.02 |
$20,400 |
D/D |
20,000 |
60,000 |
2.74 |
- |
|
67 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|